CTRI/2026/07/114048进行中（未招募）不适用
A Prospective Interventional Study on the Effectiveness of Individualised Homoeopathic Medicines in the Management of Tension-Type Headache - NIL
Ahmedabad Homoeopathic Medical college attached to Sainath Hospital0 个研究点目标入组 30 人开始时间: 2026年7月25日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Diagnosed with Tension-Type headache as per international classification of headache disorder-3[ICHD-3]
- •HIT-6 Score greater than or equal to 50
- •Willing to provide informed consent and comply with follow-up.
排除标准
- •Headache due to secondary causes
- •Other primary headache disorders like Migraine, Cluster headache, Medication overuse headache, etc
- •Recent use of prophylactic medicines
- •Pregnant and lactating females
- •Unwilling to participate
研究者
相似试验
尚未招募
不适用
Evaluating the Effects of Acupuncture on Mental HealthDepressionjRCT103226031180
尚未招募
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared with Placebo in Adults with Type 2 Diabetes Mellitus on
Background Insulin (Eluminate-3)Type 2 Diabetes MellitusjRCT203126026280
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)Type 2 Diabetes MellitusjRCT2031260261165
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin (Eluminate-4)Type 2 Diabetes Mellitus and Impaired Renal FunctionjRCT2031260268118
尚未招募
不适用
A Phase III, Randomised, Double-blind, Study to Evaluate the Effect of Balcinrenone/Dapagliflozin Compared With Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Chronic Kidney Disease (Stage 3b and 4)Renal Insufficiency, ChronicjRCT2031260364200